Combining BRAF and MEK inhibitors in melanoma treatment led to significant overall survival improvements and prevents relapse by 50% in the adjuvant setting.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.